Current and historical daily PE Ratio for PODD (
Insulet Corp
) from 2007 to Jul 26 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Insulet stock (PODD) PE ratio as of Jul 26 2024 is 58.58.
More Details
Insulet Corp (PODD) PE Ratio (TTM) Chart
Insulet Corp (PODD) PE Ratio (TTM) Historical Data
View and export this data going back to 2007. Start your Free Trial
Total 1214
- 1
- 2
- 3
- 4
- 5
- 6
- 14
Insulet PE Ratio (TTM) Historical Data | |||
---|---|---|---|
Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
2024-07-27 | 58.6 | 2024-05-21 | 55.4 |
2024-07-25 | 57.8 | 2024-05-20 | 55.8 |
2024-07-24 | 58.9 | 2024-05-17 | 56.8 |
2024-07-23 | 59.6 | 2024-05-16 | 56.2 |
2024-07-22 | 58.9 | 2024-05-15 | 54.7 |
2024-07-19 | 59.1 | 2024-05-14 | 52.2 |
2024-07-18 | 59.1 | 2024-05-13 | 48.8 |
2024-07-17 | 59.9 | 2024-05-10 | 50.3 |
2024-07-16 | 61.0 | 2024-05-09 | 53.8 |
2024-07-15 | 60.3 | 2024-05-08 | 53.2 |
2024-07-12 | 61.2 | 2024-05-07 | 55.8 |
2024-07-11 | 61.7 | 2024-05-06 | 53.5 |
2024-07-10 | 59.9 | 2024-05-03 | 52.9 |
2024-07-09 | 59.1 | 2024-05-02 | 52.5 |
2024-07-08 | 60.2 | 2024-05-01 | 51.6 |
2024-07-05 | 59.7 | 2024-04-30 | 52.1 |
2024-07-03 | 59.6 | 2024-04-29 | 51.6 |
2024-07-02 | 59.8 | 2024-04-26 | 50.4 |
2024-07-01 | 59.4 | 2024-04-25 | 49.8 |
2024-06-28 | 61.1 | 2024-04-24 | 50.7 |
2024-06-27 | 62.7 | 2024-04-23 | 50.7 |
2024-06-26 | 62.7 | 2024-04-22 | 49.8 |
2024-06-25 | 62.4 | 2024-04-19 | 50.4 |
2024-06-24 | 61.8 | 2024-04-18 | 49.9 |
2024-06-21 | 61.9 | 2024-04-17 | 50.4 |
2024-06-20 | 60.4 | 2024-04-16 | 52.3 |
2024-06-18 | 59.5 | 2024-04-15 | 52.7 |
2024-06-17 | 60.1 | 2024-04-12 | 53.1 |
2024-06-14 | 60.7 | 2024-04-11 | 54.4 |
2024-06-13 | 61.2 | 2024-04-10 | 53.8 |
2024-06-12 | 60.8 | 2024-04-09 | 53.9 |
2024-06-11 | 58.2 | 2024-04-08 | 51.5 |
2024-06-10 | 58.2 | 2024-04-05 | 50.0 |
2024-06-07 | 58.0 | 2024-04-04 | 49.5 |
2024-06-06 | 58.3 | 2024-04-03 | 50.0 |
2024-06-05 | 56.9 | 2024-04-02 | 49.7 |
2024-06-04 | 55.1 | 2024-04-01 | 50.9 |
2024-06-03 | 55.0 | 2024-03-28 | 51.9 |
2024-05-31 | 53.7 | 2024-03-27 | 58.1 |
2024-05-30 | 53.3 | 2024-03-26 | 56.9 |
2024-05-29 | 52.2 | 2024-03-25 | 56.6 |
2024-05-28 | 53.9 | 2024-03-22 | 56.5 |
2024-05-24 | 54.6 | 2024-03-21 | 57.3 |
2024-05-23 | 51.8 | 2024-03-20 | 57.5 |
2024-05-22 | 54.9 | 2024-03-19 | 58.6 |
Insulet Corp (PODD) PE Ratio (TTM) Comparison
Company | Market Cap(Mil) | PE Ratio (TTM) |
---|
Business Description
Business Description
![Insulet Corp Insulet Corp logo](https://static.gurufocus.com/logos/0C00000PUY.png?14)
Insulet Corp
NAICS : 339112
SIC : 3841
ISIN : US45784P1012
Share Class Description:
PODD: Ordinary SharesDescription
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 425,000 insulin-dependent diabetics are using it worldwide.